Delivery Order SPE2DB25D3201-SPE2DB26FNNXM
Award Date 11/6/25
Potential Completion Date 12/1/25
Potential Value $15K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $5,543.85 to AmerisourceBergen Drug Corp for Padcev 20 mg vials on November 4, 2025, with an ultimate completion date of November 26, 2025. This firm fixed-price delivery order is non-set-aside and competitively awarded, with performance to be fulfilled at the contractor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,847.95 to AmerisourceBergen Drug Corp for the supply of Padcev 20 mg vials, with an ultimate completion date of September 16, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $14,783.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for 20 mg vials of Padcev, a specialized oncology medication. The contract, which is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), is scheduled for completion by October 6, 2025. The pharmaceutical will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, and no...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $7,391.80 delivery order for Padcev 20 mg vials under a firm fixed-price contract with an ultimate completion date of August 11, 2025. This is a non-set-aside award, meaning it was competitively awarded without restrictions. The order will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company operates as a major pharmaceutical distributor serving federal medical procurement needs,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,543.85 to AmerisourceBergen Drug Corp for the supply of Padcev 20 mg vials, with an ultimate completion date of August 29, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order for PADCEV 20 MG vials valued at $3,695.90 by the Defense Logistics Agency (DLA). This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 2, 2025, with no set-aside designation applied. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal healthcare systems, leveraging the...
- The Defense Logistics Agency awarded a delivery order valued at $5,543.80 to AmerisourceBergen Drug Corp for the supply of PADCEV 30 mg vials. This contract is a firm fixed-price delivery order with no set-aside designation, issued competitively on July 21, 2025, and scheduled for completion by August 11, 2025. The products will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This award represents a child...
- AmerisourceBergen Drug Corp was awarded a $27.7K delivery order by the Defense Logistics Agency's Medical Supply Chain to supply 30 mg vials of Padcev, a specialized oncology medication. The contract, executed on September 2, 2025, with completion targeted for September 23, 2025, represents a firm fixed-price, non-set-aside competitive award. Performance will be executed from the contractor's Conshohocken, Pennsylvania location, which serves as the company's corporate headquarters and primary...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of PADCEV 30 MG vials. The contract is a firm fixed-price delivery order with a ceiling value of $39,998.88 and is set to be completed by September 5, 2024. Amerisourcebergen is providing these critical pharmaceutical products to support military treatment facilities and other federal healthcare providers. This delivery order is part...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $27,719 on July 28, 2025, for the supply of Padcev 30 mg vials. This firm fixed-price delivery order, which is expected to be completed by August 18, 2025, was issued without a set-aside designation, indicating it was competitively awarded. The contract is performed at the awardee's Corporate Office location in Conshohocken, PA and is funded...